2,233 Shares in The Cigna Group (NYSE:CI) Purchased by Dynamic Technology Lab Private Ltd

Dynamic Technology Lab Private Ltd bought a new stake in The Cigna Group (NYSE:CI) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm bought 2,233 shares of the health services provider’s stock, valued at approximately $669,000.

Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Private Advisor Group LLC boosted its stake in The Cigna Group by 42.4% in the third quarter. Private Advisor Group LLC now owns 20,749 shares of the health services provider’s stock valued at $6,025,000 after buying an additional 6,180 shares in the last quarter. OVERSEA CHINESE BANKING Corp Ltd boosted its stake in shares of The Cigna Group by 41.5% in the 3rd quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,268 shares of the health services provider’s stock valued at $363,000 after purchasing an additional 372 shares in the last quarter. Corient Private Wealth LLC grew its holdings in shares of The Cigna Group by 3.6% during the 3rd quarter. Corient Private Wealth LLC now owns 104,618 shares of the health services provider’s stock valued at $29,929,000 after purchasing an additional 3,664 shares during the last quarter. Signaturefd LLC increased its position in The Cigna Group by 2.9% during the 3rd quarter. Signaturefd LLC now owns 4,822 shares of the health services provider’s stock worth $1,379,000 after purchasing an additional 138 shares in the last quarter. Finally, Capula Management Ltd bought a new position in The Cigna Group in the 3rd quarter valued at approximately $252,000. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of The Cigna Group stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $348.71, for a total value of $2,073,429.66. Following the completion of the sale, the senior vice president now owns 2,595 shares in the company, valued at approximately $904,902.45. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, SVP Hoeltzel Mary T. Agoglia sold 5,946 shares of the stock in a transaction dated Tuesday, May 14th. The shares were sold at an average price of $348.71, for a total transaction of $2,073,429.66. Following the transaction, the senior vice president now owns 2,595 shares of the company’s stock, valued at approximately $904,902.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO David Cordani sold 2,000 shares of the business’s stock in a transaction dated Tuesday, February 27th. The shares were sold at an average price of $345.04, for a total value of $690,080.00. Following the completion of the sale, the chief executive officer now directly owns 336,783 shares of the company’s stock, valued at $116,203,606.32. The disclosure for this sale can be found here. Insiders sold 72,366 shares of company stock valued at $25,440,835 over the last 90 days. Company insiders own 0.60% of the company’s stock.

The Cigna Group Stock Up 0.4 %

Shares of NYSE CI opened at $337.83 on Friday. The company’s 50 day moving average price is $351.38 and its 200-day moving average price is $322.97. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.71 and a current ratio of 0.71. The Cigna Group has a 52-week low of $240.50 and a 52-week high of $365.71. The company has a market capitalization of $95.97 billion, a P/E ratio of 27.74, a price-to-earnings-growth ratio of 1.03 and a beta of 0.57.

The Cigna Group (NYSE:CI) last released its earnings results on Thursday, May 2nd. The health services provider reported $6.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.17 by $0.30. The Cigna Group had a net margin of 1.76% and a return on equity of 17.24%. The business had revenue of $57.25 billion for the quarter, compared to analyst estimates of $56.59 billion. During the same quarter in the previous year, the business earned $5.41 earnings per share. The Cigna Group’s revenue for the quarter was up 23.2% on a year-over-year basis. Equities analysts forecast that The Cigna Group will post 28.47 earnings per share for the current year.

The Cigna Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, June 20th. Investors of record on Tuesday, June 4th will be given a dividend of $1.40 per share. The ex-dividend date is Tuesday, June 4th. This represents a $5.60 annualized dividend and a dividend yield of 1.66%. The Cigna Group’s payout ratio is 45.98%.

Wall Street Analyst Weigh In

CI has been the subject of several research analyst reports. Mizuho upped their price target on shares of The Cigna Group from $360.00 to $370.00 and gave the stock a “buy” rating in a report on Monday, February 5th. Wells Fargo & Company upped their target price on The Cigna Group from $334.00 to $348.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 6th. Barclays assumed coverage on The Cigna Group in a research note on Wednesday, March 6th. They set an “overweight” rating and a $393.00 price target on the stock. StockNews.com raised The Cigna Group from a “buy” rating to a “strong-buy” rating in a research note on Thursday, March 14th. Finally, Deutsche Bank Aktiengesellschaft upgraded shares of The Cigna Group from a “hold” rating to a “buy” rating and lifted their target price for the stock from $355.00 to $370.00 in a research report on Thursday, February 1st. Two equities research analysts have rated the stock with a hold rating, ten have given a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of $366.14.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.